Yigit Gul

Andrei Marian Feier, Veysel Kocaman, Yigit Gul et al.

Large language models (LLMs) are increasingly deployed across healthcare, yet existing benchmarks fail to capture model behavior under adversarial or ethically complex conditions common in clinical practice. We developed a multi-domain red teaming framework evaluating eleven contemporary LLMs across 690 clinically grounded scenarios spanning nine domains and over 150 subcategories. Scenarios incorporated adversarial transformations, and responses were assessed using a seven-dimension rubric with LLM-assisted scoring and human-in-the-loop validation. Results revealed substantial performance variance, with mean scores ranging from 0.791 to 0.984. Critically, several high-performing systems produced complete failures in individual safety-critical scenarios, demonstrating that aggregate accuracy masks clinically meaningful risk. The highest-performing systems (X-BAI, GPT-5, Claude Opus 4.1) achieved scores above 0.97 with low variance, while performance varied significantly across domains. Equity-related tasks showed 10-20% error amplification with demographic modifications, and human reviewers identified clinically relevant failures missed by automated evaluation. Our findings demonstrate that performance variance and worst-case failures provide more clinically meaningful reliability indicators than mean accuracy alone, and that hybrid evaluation approaches combining automation with clinician oversight are essential for credible safety assessment.

Veysel Kocaman, Gursev Pirge, Yigit Gul et al.

Extracting detailed clinical information from free-text medical narratives remains a practical challenge for researchers and healthcare systems. Terminology for immune-mediated and infectious diseases is especially inconsistent across sources, which often limits the ability of general-purpose Natural Language Processing (NLP) systems to capture the relevant biomedical concepts with sufficient granularity. We developed a domain-specific Named Entity Recognition (NER) model tailored to identify disease-related entities occurring in immunology and infectious disease contexts. We assembled and manually annotated a dataset of 371 case reports in collaboration with two clinical specialists, defining twelve entity classes covering immune-mediated and infectious conditions as well as related symptoms and clinical descriptors. We evaluated several modeling strategies, including the MedicalNER architecture with multiple healthcare-specific embeddings, a BERT-based token classification model, and zero-shot NER systems. The strongest performance was obtained with a transformer-based model trained on clinical-domain embeddings, which reached an F1 score of 0.89, consistently outperforming baseline and zero-shot approaches. The combination of specialized embeddings and expert annotation proved particularly valuable for capturing nuanced disease terminology and improving generalization across heterogeneous biomedical text. The prompted LLM baseline achieved substantially lower performance under the same evaluation protocol, reflecting difficulties in producing span-consistent outputs for fine-grained entity boundaries despite detailed prompting. The resulting model provides a structured way to analyze case reports and can support downstream tasks such as cohort identification, disease monitoring, and clinical decision support.

Veysel Kocaman, Yigit Gul, M. Aytug Kaya et al.

Assertion status detection is a critical yet often overlooked component of clinical NLP, essential for accurately attributing extracted medical facts. Past studies have narrowly focused on negation detection, leading to underperforming commercial solutions such as AWS Medical Comprehend, Azure AI Text Analytics, and GPT-4o due to their limited domain adaptation. To address this gap, we developed state-of-the-art assertion detection models, including fine-tuned LLMs, transformer-based classifiers, few-shot classifiers, and deep learning (DL) approaches. We evaluated these models against cloud-based commercial API solutions, the legacy rule-based NegEx approach, and GPT-4o. Our fine-tuned LLM achieves the highest overall accuracy (0.962), outperforming GPT-4o (0.901) and commercial APIs by a notable margin, particularly excelling in Present (+4.2%), Absent (+8.4%), and Hypothetical (+23.4%) assertions. Our DL-based models surpass commercial solutions in Conditional (+5.3%) and Associated-with-Someone-Else (+10.1%) categories, while the few-shot classifier offers a lightweight yet highly competitive alternative (0.929), making it ideal for resource-constrained environments. Integrated within Spark NLP, our models consistently outperform black-box commercial solutions while enabling scalable inference and seamless integration with medical NER, Relation Extraction, and Terminology Resolution. These results reinforce the importance of domain-adapted, transparent, and customizable clinical NLP solutions over general-purpose LLMs and proprietary APIs.

Veysel Kocaman, Muhammed Santas, Yigit Gul et al.

We evaluate the performance of four leading solutions for de-identification of unstructured medical text - Azure Health Data Services, AWS Comprehend Medical, OpenAI GPT-4o, and John Snow Labs - on a ground truth dataset of 48 clinical documents annotated by medical experts. The analysis, conducted at both entity-level and token-level, suggests that John Snow Labs' Medical Language Models solution achieves the highest accuracy, with a 96% F1-score in protected health information (PHI) detection, outperforming Azure (91%), AWS (83%), and GPT-4o (79%). John Snow Labs is not only the only solution which achieves regulatory-grade accuracy (surpassing that of human experts) but is also the most cost-effective solution: It is over 80% cheaper compared to Azure and GPT-4o, and is the only solution not priced by token. Its fixed-cost local deployment model avoids the escalating per-request fees of cloud-based services, making it a scalable and economical choice.